GLP-1 drugs: what Delaware Medicaid paid

Q: Does a paid prescription mean Delaware Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Delaware Medicaid shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Delaware Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Delaware Medicaid’s payment record shows

In 2026Q1, the product Delaware Medicaid paid for most often was Ozempic®, at 3,872 prescriptions¹⁹ of the 10,123 to 10,366^1,7,13,19,25 across all 8 products, or 38 percent of the published count.

Delaware Medicaid itself reimbursed at least $3,944,233 for these products in the quarter, about $391 per prescription. Pharmacies were paid $4,290,687 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,126.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Delaware Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Delaware Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Delaware Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Delaware Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 2,547¹	25%	$263	$35,013	$0
tirzepatideMounjaro®	Managed care	at least 863⁷	9%	$273	$39,843	$0
semaglutideWegovy®	Managed care	at least 2,738¹³	27%	$3,950	$204,226	$1
semaglutideOzempic®	Managed care	at least 3,872¹⁹	38%	$3,854,207	$3,923,365	$995
semaglutideRybelsus®	Managed care	at least 76²⁵	<1%	$85,540	$88,239	$1,126
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Managed care	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through managed care, meaning a plan the program contracts with paid the pharmacy. This record shows no fee-for-service claims for these products. That is a fact about how the file reports, and it points at who to ask: the plan named on your card.

Against enrollment, that is 45.1 to 46.2 prescriptions per thousand people enrolled in Delaware Medicaid, on an average of 224,604 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 15 of the 168 product-quarters it holds a row for here, which is 9 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Delaware Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Delaware Medicaid paid for each product, quarter by quarter

Prescriptions Delaware Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 22 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$0 paid	at least 632 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$0 paid	at least 831 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$0 paid	at least 1,144 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$0 paid	at least 1,122 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$0 paid	at least 1,822 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$0 paid	at least 2,932 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$0 paid	at least 3,679 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$530 paid	at least 4,351 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$2,357 paid	at least 2,547 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$263 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld3 of 3 product codes withheld	at least 31 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$238 paid	at least 129 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$468 paid	at least 164 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$0 paid	235 paid prescriptions in the quarter (2023Q3)¹⁰Count$492 paid	at least 306 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$0 paid	at least 376 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$0 paid	at least 408 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$0 paid	at least 426 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$0 paid	at least 567 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$0 paid	at least 589 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$0 paid	at least 703 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$0 paid	at least 819 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$1,319 paid	at least 876 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$0 paid	at least 863 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$273 paid
semaglutideWegovy®range 286 to 4,982	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	at least 12 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld¹⁸At least$0 paid	at least 159 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld¹⁸At least$0 paid	at least 305 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$0 paid	286 paid prescriptions in the quarter (2022Q2)¹⁷Count$0 paid	at least 198 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$0 paid	at least 160 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$0 paid	at least 820 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$322 paid	at least 1,462 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$324 paid	at least 913 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$325 paid	764 paid prescriptions in the quarter (2023Q4)¹⁶Count$0 paid	837 paid prescriptions in the quarter (2024Q1)¹⁵Count$0 paid	2,081 paid prescriptions in the quarter (2024Q2)¹⁵Count$0 paid	at least 3,080 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$0 paid	at least 3,788 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$0 paid	at least 4,502 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$0 paid	at least 4,591 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$0 paid	at least 4,690 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$333 paid	4,982 paid prescriptions in the quarter (2025Q4)¹⁴Count$663 paid	at least 2,738 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$3,950 paid
semaglutideOzempic®	at least 1,251 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$998,661 paid	at least 1,387 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,134,776 paid	at least 1,699 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$1,403,876 paid	at least 1,899 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,564,431 paid	at least 2,051 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,741,510 paid	at least 2,222 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,893,429 paid	at least 2,376 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$2,024,496 paid	at least 2,625 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,254,585 paid	at least 3,287 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$2,940,835 paid	at least 4,389 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$3,922,344 paid	at least 4,794 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$4,287,668 paid	at least 4,258 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$3,789,042 paid	at least 4,627 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$4,257,809 paid	at least 5,222 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$4,843,437 paid	at least 5,000 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$4,638,269 paid	at least 4,617 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$4,289,100 paid	at least 4,447 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$4,251,091 paid	at least 4,291 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$4,111,866 paid	at least 4,265 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$4,098,635 paid	at least 4,131 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$3,986,777 paid	at least 3,872 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$3,854,207 paid
semaglutideRybelsus®range 73 to 130	at least 13 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$10,302 paid	at least 43 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$33,456 paid	73 paid prescriptions in the quarter (2021Q3)³⁰Count$60,115 paid	at least 71 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$58,096 paid	at least 70 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$60,411 paid	at least 79 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$70,721 paid	at least 84 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$69,431 paid	at least 80 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$68,742 paid	at least 111 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$95,040 paid	at least 135 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$107,720 paid	at least 147 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$116,645 paid	at least 157 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$127,788 paid	124 paid prescriptions in the quarter (2024Q1)²⁷Count$106,504 paid	130 paid prescriptions in the quarter (2024Q2)²⁷Count$120,208 paid	109 paid prescriptions in the quarter (2024Q3)²⁷Count$100,631 paid	118 paid prescriptions in the quarter (2024Q4)²⁷Count$108,924 paid	113 paid prescriptions in the quarter (2025Q1)²⁶Count$106,698 paid	105 paid prescriptions in the quarter (2025Q2)²⁶Count$101,161 paid	98 paid prescriptions in the quarter (2025Q3)²⁶Count$95,037 paid	98 paid prescriptions in the quarter (2025Q4)²⁶Count$95,063 paid	at least 76 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$85,540 paid
liraglutideSaxenda®range 13 to 460	115 paid prescriptions in the quarter (2021Q1)³⁶Count$767 paid	at least 153 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁶At least$1,841 paid	169 paid prescriptions in the quarter (2021Q3)³⁶Count$1,584 paid	181 paid prescriptions in the quarter (2021Q4)³⁶Count$4,733 paid	193 paid prescriptions in the quarter (2022Q1)³⁵Count$4,157 paid	240 paid prescriptions in the quarter (2022Q2)³⁵Count$6,777 paid	382 paid prescriptions in the quarter (2022Q3)³⁵Count$11,937 paid	460 paid prescriptions in the quarter (2022Q4)³⁵Count$11,944 paid	448 paid prescriptions in the quarter (2023Q1)³⁴Count$5,556 paid	at least 458 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld³⁴At least$13,393 paid	351 paid prescriptions in the quarter (2023Q3)³⁴Count$14,919 paid	82 paid prescriptions in the quarter (2023Q4)³⁴Count$2,629 paid	28 paid prescriptions in the quarter (2024Q1)³³Count$1,045 paid	41 paid prescriptions in the quarter (2024Q2)³³Count$1,562 paid	50 paid prescriptions in the quarter (2024Q3)³³Count$2,883 paid	70 paid prescriptions in the quarter (2024Q4)³³Count$794 paid	58 paid prescriptions in the quarter (2025Q1)³²Count$1,570 paid	27 paid prescriptions in the quarter (2025Q2)³²Count$521 paid	13 paid prescriptions in the quarter (2025Q3)³²Count$0 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 60 to 396	396 paid prescriptions in the quarter (2021Q1)⁴²Count$338,543 paid	at least 388 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld⁴²At least$339,727 paid	385 paid prescriptions in the quarter (2021Q3)⁴²Count$342,679 paid	350 paid prescriptions in the quarter (2021Q4)⁴²Count$307,792 paid	at least 339 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$312,381 paid	306 paid prescriptions in the quarter (2022Q2)⁴¹Count$284,902 paid	276 paid prescriptions in the quarter (2022Q3)⁴¹Count$253,932 paid	280 paid prescriptions in the quarter (2022Q4)⁴¹Count$263,698 paid	280 paid prescriptions in the quarter (2023Q1)⁴⁰Count$259,603 paid	211 paid prescriptions in the quarter (2023Q2)⁴⁰Count$196,103 paid	167 paid prescriptions in the quarter (2023Q3)⁴⁰Count$154,351 paid	167 paid prescriptions in the quarter (2023Q4)⁴⁰Count$145,959 paid	117 paid prescriptions in the quarter (2024Q1)³⁹Count$76,751 paid	60 paid prescriptions in the quarter (2024Q2)³⁹Count$39,735 paid	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³⁹Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld2 of 2 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	at least 11 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$7,032 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable⁴⁴Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable⁴⁴Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable⁴⁴Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable⁴⁴Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld4 of 4 product codes withheld

What this page cannot tell you

Whether Delaware Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Delaware in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, DE
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "657"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, DE
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1085"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, DE
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "426"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, DE
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "22"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, DE
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like ZEPBOUND%, state DE, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, DE
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like ZEPBOUND%, state DE, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, DE
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "181"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, DE
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "184"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, DE
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "161"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, DE
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "117"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, DE
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "20"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, DE
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like MOUNJARO%, state DE, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, DE
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "783"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, DE
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "1288"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, DE
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "1021"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, DE
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "453"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, DE
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "155"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, DE
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "76"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, DE
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1546"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, DE
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1658"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, DE
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2227"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, DE
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2471"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, DE
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1331"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, DE
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1045"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, DE
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "45"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, DE
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "48"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, DE
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "58"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, DE
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "79"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, DE
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "51"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, DE
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, DE
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like SAXENDA%, state DE, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, DE
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "58"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, DE
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "70"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, DE
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "458"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, DE
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "460"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, DE
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "181"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, DE
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, DE
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, DE
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, DE
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "162"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, DE
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "246"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, DE
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "278"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, DE
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state DE, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DE", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, DE
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state DE, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, DE
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state DE, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, DE
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state DE, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like LIRAGLUTID%, state DE, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, DE
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state DE, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like LIRAGLUTID%, state DE, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, DE
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state DE, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DE", "product_name": "product_name like LIRAGLUTID%, state DE, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 41 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 7 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Delaware Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.